Willingjet Life Science
Willingjet Life Science, headquartered in China, is a prominent player in the biotechnology and life sciences industry. Founded in 2015, the company has rapidly established itself as a leader in the development of innovative solutions for drug discovery and development. With a focus on advanced biopharmaceuticals and cutting-edge research services, Willingjet offers unique products that streamline the drug development process, enhancing efficiency and accuracy. Operating primarily in Asia and expanding into global markets, Willingjet Life Science has achieved significant milestones, including partnerships with leading research institutions. Their commitment to quality and innovation has positioned them as a trusted partner in the life sciences sector, recognised for their expertise in high-throughput screening and custom assay development.
DitchCarbon Score
How does Willingjet Life Science's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Willingjet Life Science's score of 3 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Willingjet Life Science's reported carbon emissions
Willingjet Life Science, headquartered in China, has set ambitious climate commitments aimed at significantly reducing its carbon footprint. Although specific emissions data for the most recent year is not available, the company has established a target to reduce its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 42% by the year 2030, using 2022 as the baseline year. This target has been validated through a streamlined process designed for small and medium-sized enterprises (SMEs) and aligns with the necessary reductions to limit global warming to 1.5°C. In addition to its Scope 1 and Scope 2 commitments, Willingjet Life Science is also focused on measuring and reducing its Scope 3 emissions, which encompass indirect emissions from the company's value chain. These initiatives reflect the company's dedication to sustainability and its proactive approach to addressing climate change within the professional services sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Willingjet Life Science is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
